^
BIOMARKER:

Chr t(14;16)

Chr t(14;16)
Multiple Myeloma
DVD
Sensitive: B - Late Trials
Chr t(14;16)
Multiple Myeloma
daratumumab
Sensitive: B - Late Trials
Chr t(14;16)
Multiple Myeloma
Isa-KRd
Sensitive: C3 – Early Trials
Chr t(14;16)
Multiple Myeloma
Proteasome inhibitor + Immunomodulator
Sensitive: C3 – Early Trials
Chr t(14;16)
Multiple Myeloma
ixazomib
Sensitive: C3 – Early Trials